A

Aquestive Therapeutics
D

AQST

4.11000
USD
-0.01
(-0.12%)
مغلق
حجم التداول
72,508
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
409,864,140
أصول ذات صلة
A
ACRE
-0.01000
(-0.22%)
4.50500 USD
A
ADMA
0.035
(0.21%)
17.000 USD
ALNY
ALNY
6.65
(1.50%)
449.19 USD
A
ANIP
-2.610
(-2.90%)
87.390 USD
A
ARWR
1.730
(9.21%)
20.510 USD
A
AXSM
0.460
(0.42%)
109.210 USD
B
BCRX
-0.09000
(-1.06%)
8.36500 USD
B
BHC
0.82500
(10.97%)
8.34500 USD
C
CRBP
-0.26000
(-2.72%)
9.31000 USD
المزيد
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.